NCT07561216

Brief Summary

This randomized clinical trial aims to evaluate and compare the clinical performance of injectable bioactive composite (Beautifil Flow Plus X, Shofu) versus Resin Modified Glass Ionomer (RMGI) in restoring proximal cavities (Class II) in primary molars of children aged 3-8 years over a 12-month follow-up period, using revised FDI criteria.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Sep 2027

First Submitted

Initial submission to the registry

February 18, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

February 18, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

Randomized Clinical TrialPrimary DentitionGiomerRMGIFDI criteria

Outcome Measures

Primary Outcomes (1)

  • Secondary Caries

    Assessed using revised FDI criteria (B1: caries at restoration margin). Evaluated by visual examination and short air drying. Scored on ordinal scale 1-5.

    Baseline, 3, 6, and 12 months

Secondary Outcomes (5)

  • Postoperative sensitivity / pulp status

    Baseline, 3, 6, and 12 months

  • Marginal Adaptation

    Baseline, 3, 6, and 12 months

  • Proximal Contact Point

    Baseline, 3, 6, and 12 months

  • Occlusal Wear

    Baseline, 3, 6, and 12 months

  • Fracture and Retention

    Baseline, 3, 6, and 12 months

Study Arms (2)

RMGIC

ACTIVE COMPARATOR

cavity restorations in primary molars using a resin-modified glass ionomer cement. Following standard cavity preparation, the RMGI material will be placed according to the manufacturer's instructions. Clinical performance will be evaluated over the follow-up period in terms of restoration retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall clinical success.

Other: giomer

giomer

EXPERIMENTAL

restoration of proximal cavities in primary molars using an injectable bioactive composite (Giomer) material. Cavities will be prepared following minimally invasive principles, isolated appropriately, and restored according to the manufacturer's instructions using adhesive bonding. Clinical performance will be evaluated in terms of retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall restoration success during the follow-up period.

Other: RMGI

Interventions

giomerOTHER

restoration of proximal cavities in primary molars using an injectable bioactive composite (Giomer) material. Cavities will be prepared following minimally invasive principles, isolated appropriately, and restored according to the manufacturer's instructions using adhesive bonding. Clinical performance will be evaluated in terms of retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall restoration success during the follow-up period.

RMGIC
RMGIOTHER

Resin-Modified Glass Ionomer (RMGI) is a fluoride-releasing restorative material used for the restoration of carious primary teeth. It combines the properties of conventional glass ionomer cement with resin components to improve mechanical strength, adhesion, and moisture tolerance. In this study, RMGI will be used for restoring cavitated carious lesions in primary teeth following caries removal according to minimally invasive dentistry principles.

giomer

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 3-8 years of both genders
  • Cooperative behavior manageable by operators
  • Willing to sign informed consent
  • Accepts the follow-up period
  • Moderate to low caries risk according to Cariogram application
  • Posterior primary molar with proximal carious lesion (ICDAS 3 or 4) with no signs or symptoms of pulpal involvement
  • Radiographically extending to outer 1/3 of dentin

You may not qualify if:

  • Allergy to any restorative materials
  • Patients undergoing orthodontic treatment with fixed appliances
  • Patients with debilitating systemic diseases
  • Children with special needs
  • Teeth with previous restorations
  • Periapical radiolucencies or sensitivity to percussion
  • Mobile teeth
  • External or internal resorption
  • Cervical carious lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Officials

  • Nadine Elshayal

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Dina Ez Mohamed

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Osama Elshahawy

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Nadine Elsayed Ahmed Elshayal

CONTACT

Dina Mohamed

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Blinding of operators, patients, parents and outcome assessors was not possible as both materials differ in appearance and application technique.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's Student

Study Record Dates

First Submitted

February 18, 2026

First Posted

May 1, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share